ABBV vs PFE
By Alex · Tickerpine
AbbVie Inc. vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | PFE |
|---|---|---|
| Price | $264.34 | $28.67 |
| Market cap | $467.12B | $163.41B |
| P/E ratio | 74.5 | 37.7 |
| ROE | — | 5.01% |
| Profit margin | 9.80% | 6.80% |
| Revenue growth | 10.20% | 2.60% |
| Dividend yield | 2.62% | 6.00% |
| Beta | 0.28 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs PFE in plain English
- ABBV is the bigger company — about 2.9× the market cap of PFE.
- PFE is cheaper on earnings (P/E 37.7 vs 74.5).
- ABBV is growing revenue faster (10% vs 3%).
- PFE has the higher dividend yield (6.00% vs 2.62%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.